SRCM
WST icon

Signature Resources Capital Management’s West Pharmaceutical WST Stock Holding History

Signature Resources Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Hold
6
– – ﹤0.01% 535
2026
Q1 		$1.5K Hold
6
– – ﹤0.01% 560
2025
Q4 		$1.65K Buy
6
+3
+100% +$821 ﹤0.01% 507
2025
Q3 		$787 Hold
3
– – ﹤0.01% 482
2025
Q2 		$656 Buy
+3
New +$641 ﹤0.01% 499

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Signature Resources Capital Management's WST Position: Q2 2026 in Review

Signature Resources Capital Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 6 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

Signature Resources Capital Management first reported a position in WST in Q2 2025 and has held it in 5 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Signature Resources Capital Management held 6 shares of West Pharmaceutical worth $2.15K as of Q2 2026.
  • Signature Resources Capital Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #535 holding.
  • Signature Resources Capital Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.